(Reuters) – Use of Johnson & Johnson’s COVID-19 vaccine should be resumed in the United States as specified under its emergency use authorization by the U.S. Food and Drug Administration, advisers to the U.S. Centers for Disease Control and Prevention recommended on Friday.
(Reporting by Manas Mishra in Bengaluru and Julie Steenhuysen in Chicago)
Watch the NFL Draft with amNY
NFL to open academy in Australia to identify and develop young prospects
Anze Kopitar scores in overtime, Kings beat Oilers 5-4 in Game 2 to tie series
Defending champion Golden Knights beat Stars 3-1 to take 2-0 series lead home to Vegas
Shai Gilgeous-Alexander’s 33 points lead Thunder past Pelicans 124-92 as OKC takes a 2-0 lead
The Latest: Trump takes to social media before Supreme Court arguments
Amazon cloud computing unit plans to invest $11 billion to build data center in northern Indiana
China launches 3-member crew to its space station as it seeks to put astronauts on the moon by 2030
Heartless perp in Midtown grabs senior’s walker in assault: cops
Controversy over spiked antifascist speech dominates Italy’s Liberation Day anniversary
Tough new EPA rules would force coal-fired power plants to capture emissions or shut down
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
US births fell last year, marking an end to the late pandemic rebound, experts say
